Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Lot Release

Lot Release

                        Lot Distribution Database (LDD)
          Seasonal Information for Influenza Virus Vaccine Home
          Vaccines, Blood & Biologics
          Guidance, Compliance & Regulatory Information (Biologics)
          Biologics Post-Market Activities
          Lot Release
          Lot Distribution Database (LDD)Lot Release Lot Distribution Database (LDD)
  
  	
    Share
    Post
    Linkedin

    Email
    PrintBackground

This procedure is intended to assist manufacturers of vaccines and other biological products to electronically submit post marketing lot distribution data to FDA under 21 CFR 600.81.

Most manufacturers have submitted biological product lot distribution reports required under *21 CFR 600.81* in the form of printed paper reports, sometimes accompanied by electronic data files as American Standard Code for Information Interchange (ASCII) flat files, XML files or in other formats. FDA staff members then manually compiled the data into the Lot Distribution Database (LDD) system for use in post marketing safety surveillance.

On June 10, 2014, FDA issued a rule which, among other things, amended 21 CFR 600.81 to require applicants to submit Lot distribution reports to FDA in an electronic format that the Agency can process, review and archive. This reporting requirement is effective as of June 10, 2015. In addition, the Agency has issued a Draft Guidance for Industry on Electronic Submission of Lot Distribution Reports, which provides information on how to submit the reports (e.g., method of transmission, media, file formats, preparation and organization of files).

Electronic Submission of Lot Distribution Data

Manufacturers can now begin electronic submission of post marketing lot distribution data for all regulated vaccine and other biological products marketed with biologic license applications (BLAs). In accordance with current automation initiatives, the FDA is moving toward electronic submission of all regulatory data in computer-readable formats in compliance with Health Level Seven (HL7) Structured Product Labeling (SPL) requirements http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/default.htm. The improved data file format provides a standardized and consistent presentation of lot distribution information that can be automatically transferred and validated against FDA’s Regulatory Management system, which tracks licensed FDA products and manufacturers.

Step by Step Submission Instructions:

Please follow these steps to begin submitting LDD Reports electronically:

**Step 1**
Contact CBERSPL@FDA.HHS.GOV to advise FDA of your intent to begin submitting LDD Reports electronically. First time users should review FDA's Electronic Submission Gateway (ESG) User Guide that provides industry participants with information and guidance on how to use the FDA ESG.

**Step 2**
Review FDA’s Draft Guidance for Industry: Electronic Submission of Lot Distribution Reports. SPL-compliant standards and data elements to be included in LDD submissions can be found in section 16.1 of the Structured Product Labeling Implementation Guide with Validation Procedures.

**Step 3**
Submit a test file using FDA Test environment (provide link to the documentation you have for conducting pilot test). If the test file is compliant with technical requirements, then the LDD system will return an email test acknowledgment receipt with notification for data acceptance. If the test is not successful, review Step 2. For further information/assistance contact SPL@fda.hhs.gov.

For assistance with CBER LDD submissions, contact CBERSPL@FDA.HHS.GOV.

Related Information

21 CFR 600.81 Distribution reports
	User Guide

                                                                                  Content current as of:
      03/22/2018
              
              
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  Flu VaccineLot Release

          
                        Lot Distribution Database (LDD)
          Seasonal Information for Influenza Virus Vaccine
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop